Universe Pharmaceuticals Inc.（UPC）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · UPC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-09	2024-09	2023-09	2022-09	2021-09
Revenue
Revenue	$17.86M	$23.02M	$32.31M	$40.14M	$47.98M
Cost of Revenue	$11.56M	$16.95M	$21.99M	$18.25M	$22.66M
Gross Profit	$6.30M	$6.07M	$10.32M	$21.89M	$25.33M
Gross Margin %(computed)	35.28%	26.37%	31.93%	54.53%	52.78%
Operating Expenses
R&D Expenses	$0.67M	$3.03M	$4.86M	$7.62M	$5.47M
G&A Expenses	$4.21M	$3.19M	$2.22M	$2.53M	$3.30M
Total Operating Expenses	$9.22M	$14.09M	$13.84M	$28.91M	$11.74M
Operating Income	($2.92M)	($8.02M)	($3.53M)	($7.02M)	$13.59M
Operating Margin %(computed)	-16.33%	-34.83%	-10.92%	-17.49%	28.32%
Interest Income	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$0.23M	$0.28M	$0.16M	$0.16M	$0.10M
Income Before Tax	($3.67M)	($8.12M)	($3.94M)	($7.98M)	$13.65M
Income Tax Expense	$0.00M	$0.61M	$2.25M	$0.75M	$2.36M
Net Income	($3.67M)	($8.73M)	($6.16M)	($8.74M)	$11.32M
Net Margin %(computed)	-20.56%	-37.90%	-19.08%	-21.76%	23.59%
Per Share & EBITDA
EPS (Basic)	$-1055.75	$-1436.12	$-1040.53	$-1475.02	$2147.18
Wtd Avg Shares	0.00M	0.01M	0.01M	0.01M	0.01M
EBITDA	($2.92M)	($7.36M)	($3.18M)	($6.40M)	$14.20M
EBITDA Margin %(computed)	-16.37%	-31.95%	-9.85%	-15.94%	29.59%